News Focus
News Focus
icon url

mrmainstreet

08/02/23 2:25 PM

#413431 RE: Pharmacydude #413429

Actually I like the US script trend since Denner took over, the deal with Lotus, and the China approval, although I'd like to see some more momentum in Europe.

The cash position remains strong, and I believe the company is being prepped for a sale. If Denner can get $2B that works for me. Anything more is gravy IMO.

I feel way better with the new management in place, and love that Denner has $100 mil of his own money at stake.
icon url

rosemountbomber

08/02/23 2:28 PM

#413432 RE: Pharmacydude #413429

PD, I had wanted to ask you about that Pharmacy Letter you posted on ST the other day.

In it it mentions the cost of Vascepa - $320 if I recollect. Where is that letter written and hasn’t that province issued a reimbursement decision? I was thinking Ontario.
icon url

KnowNothingJonSnow

08/02/23 2:28 PM

#413433 RE: Pharmacydude #413429

So why are you still here? Sell your shares and keep it moving.
icon url

ramfan60

08/02/23 2:56 PM

#413436 RE: Pharmacydude #413429

Pdude, unless you missed it, they had the cc when they pre-announced and introduced the new CEO and they said at the time there was no need to have a cc when they released earnings. You may want to remove that one from your grievance list.
icon url

Nukemtiltheyglow

08/02/23 8:08 PM

#413448 RE: Pharmacydude #413429

Seriously Dude get a life and take the loud mouth Rooney TOON with you.

Here's what the Newswires said;
Earnings Flash (AMRN) AMARIN CORPORATION Reports Q2 Adjusted EPS $0.02, vs. Street Est for Adjusted Loss of $-0.03 Per Share
07:14 AM EDT, 08/02/2023 (MT Newswires) --

AMRN is positive earnings, so shove that up your periscope.

So your grievance list needs to be revised.
icon url

CmTerminator

08/03/23 10:29 AM

#413454 RE: Pharmacydude #413429

If you feel so aggrieved, I would suggest you sell and move on. 1 year from now AMRN tank and you would feel even more aggrieved; if AMRN goes to even $3, you will be everyone’s laughing stock. 😅